Are your kids barking mad about dogs? Then there's no bones about it: These great dog "tails" are sure to have them yipping with glee. There are a lot of animal movies out there -- and many aren't ...

The cage was not a crib but a crate. The 3-month-old in question was not our child but our dog. We do have children, six of them. When Bruce and I got married a decade ago, our children — three ...

While unpleasant to think about, the reality is that worms are quite common in dogs. In a recent study, researchers found intestinal parasites in more than 20 percent of dogs and 85 percent of dog ...

For example, some larger breeds of dogs are more susceptible to heart and hip issues. In our analysis of filings by pet insurers to state regulators, we found many pricing levels based on dog ...

Just like people, dogs can feel pain. It could be that your dog is aging and having joint pain. Maybe your dog had surgery recently and is still recovering. Your dog might have a wound somewhere ...

How effective is ceramic car spray, really? We dive deep into the claims, performance, and results to separate the marketing hype from reality. See how this product holds up in a rigorous, hands-on ...

Reviewers have tested some of the products below and may have received some products from the manufacturers for free. All opinions are the reviewers’ own. These full-spectrum gummies are ...

Watch Maymo and his adorable pack in laugh-out-loud skits, epic pranks, and heartwarming adventures that dog lovers can't get ... to lead Secret Service The Hypnotic Process of Launching US ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...